Mary L. Faber

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets”.

Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000915

N/A

0DataRank · unranked

20 citations

Mary L. Faber, Theodore R. Keppel, Amanda R. Buchberger, Matthew Waas, Parameswaran Hari +3 more

Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity

Frontiers in Immunology(2023)10.3389/fimmu.2023.1225610

N/A

0DataRank · unranked

14 citations

Robyn A. A. Oldham, Archana Thakur, Mary Jo Rademacher, Ewa Kubicka, Theresa A. Dlugi +6 more

Cardiac dysfunction and altered gene expression in acid ceramidase-deficient mice

American Journal of Physiology-Heart and Circulatory Physiology(2024)10.1152/ajpheart.00289.2024

N/A

0DataRank · unranked

3 citations

Jitka Rybová, William M. McKillop, Theresa A. Dlugi, Mary L. Faber, Maria Fuller +3 more